Business Description
Quest Laboratories Ltd
ISIN : INE0TNW01017
Description
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC), and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | 0.45 | |||||
Debt-to-Equity | 0.18 | |||||
Debt-to-EBITDA | 1.67 | |||||
Interest Coverage | 8.68 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 59.56 | |||||
9-Day RSI | 58.71 | |||||
14-Day RSI | 54.28 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.42 | |||||
Quick Ratio | 1.03 | |||||
Days Inventory | 275.39 | |||||
Days Sales Outstanding | 548.95 | |||||
Days Payable | 717.15 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 33 | |||||
Operating Margin % | 12.42 | |||||
Net Margin % | 7.1 | |||||
FCF Margin % | 2.68 | |||||
ROE % | 7.17 | |||||
ROA % | 2.58 | |||||
ROIC % | 6 | |||||
ROC (Joel Greenblatt) % | 11.95 | |||||
ROCE % | 11.25 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 173.96 | |||||
PE Ratio without NRI | 173.96 | |||||
PS Ratio | 12.34 | |||||
PB Ratio | 9.91 | |||||
Price-to-Tangible-Book | 9.92 | |||||
Price-to-Free-Cash-Flow | 461.18 | |||||
Price-to-Operating-Cash-Flow | 71.6 | |||||
EV-to-EBIT | 99.84 | |||||
EV-to-EBITDA | 95.92 | |||||
EV-to-Revenue | 12.56 | |||||
EV-to-FCF | 411.89 | |||||
Price-to-Graham-Number | 8.76 | |||||
Price-to-Net-Current-Asset-Value | 25.47 | |||||
Earnings Yield (Greenblatt) % | 1.01 | |||||
FCF Yield % | 0.21 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Quest Laboratories Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 210.627 | ||
EPS (TTM) (₹) | 0.912 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 54.28 | ||
14-Day ATR (₹) | 13.88747 | ||
20-Day SMA (₹) | 132.095 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (₹) | 102 - 196.8 | ||
Shares Outstanding (Mil) | 16.39 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Quest Laboratories Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Quest Laboratories Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Quest Laboratories Ltd Frequently Asked Questions
What is Quest Laboratories Ltd(NSE:QUESTLAB)'s stock price today?
The current price of NSE:QUESTLAB is ₹158.65. The 52 week high of NSE:QUESTLAB is ₹196.80 and 52 week low is ₹102.00.
When is next earnings date of Quest Laboratories Ltd(NSE:QUESTLAB)?
The next earnings date of Quest Laboratories Ltd(NSE:QUESTLAB) is .
Does Quest Laboratories Ltd(NSE:QUESTLAB) pay dividends? If so, how much?
Quest Laboratories Ltd(NSE:QUESTLAB) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |